Non-Hodgkin's Lymphoma

Showing NaN - NaN of 20

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non-Hodgkin's Lymphoma, Plasma Cell Myeloma Trial in Philadelphia (procedure, drug, other)

Completed
  • Non-Hodgkin's Lymphoma
  • Plasma Cell Myeloma
  • Hematopoietic Cell Transplantation
  • +2 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 16, 2022

Non-Hodgkin's Lymphoma Trial in Philadelphia (drug, procedure, genetic)

Completed
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 14, 2022

Non-Hodgkin's Lymphoma Trial in New York, Philadelphia, Houston (hA20-humanized anti-CD20 antibody)

Completed
  • Non-Hodgkin's Lymphoma
  • hA20-humanized anti-CD20 antibody
  • New York, New York
  • +2 more
Aug 12, 2021

Non-Hodgkin's Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor

Recruiting
  • Non-Hodgkin's Lymphoma
  • +18 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Mar 11, 2021

Chronic Myelogenous Leukemia, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (CD3/CD28 Activated

Terminated
  • Chronic Myelogenous Leukemia
  • +7 more
  • CD3/CD28 Activated T cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 12, 2020

Non-Hodgkin's Lymphoma Trial in Worldwide (Obinutuzumab, Bendamustine)

Completed
  • Non-Hodgkin's Lymphoma
  • Mobile, Alabama
  • +120 more
Dec 20, 2019

Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Worldwide (Lenalidomide, Placebo)

Terminated
  • Mantle Cell Lymphoma
  • Non-Hodgkin's Lymphoma
  • San Diego, California
  • +91 more
Nov 6, 2019

Solid Tumors, Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (PLX51107)

Terminated
  • Solid Tumors
  • +3 more
  • New York, New York
  • +4 more
Dec 20, 2018

Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (bendamustine, rituximab, vincristine)

Completed
  • Non-Hodgkin's Lymphoma
  • Mantle Cell Lymphoma
  • Tucson, Arizona
  • +127 more
Jan 8, 2018

Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia Trial in Philadelphia (radiation, biological, drug)

Terminated
  • Hematologic Malignancy
  • +11 more
  • Total Body Irradiation (TBI)
  • +5 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Oct 19, 2016

Hematologic Malignancies, Acute Leukemia, MDS (MDS) Other Than RA or RARS Subtypes Trial in Philadelphia (drug, radiation,

Terminated
  • Hematologic Malignancies
  • +6 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Nov 28, 2016

B-cell Lymphoma, Non-Hodgkin's Lymphoma Trial in Philadelphia (Bexxar)

Completed
  • B-cell Lymphoma
  • Non-Hodgkin's Lymphoma
  • Philadelphia, Pennsylvania
    Abramson Cancer Center, University of Pennsylvania
Aug 15, 2016

Non-Hodgkin's Lymphoma Trial in United States (AME-133v (LY2469298))

Completed
  • Non-Hodgkin's Lymphoma
  • AME-133v (LY2469298)
  • Birmingham, Alabama
  • +10 more
Jan 5, 2016

Non-Hodgkin's Lymphoma Trial in United States (IDEC-114)

Completed
  • Non-Hodgkin's Lymphoma
  • Birmingham, Alabama
  • +21 more
Sep 12, 2013

Advanced Solid Tumors, Non-Hodgkin's Lymphoma Trial in United States (RH-1)

Terminated
  • Advanced Solid Tumors
  • Non-Hodgkin's Lymphoma
  • Aurora, Colorado
  • +3 more
May 8, 2013

Non-Hodgkin's Lymphoma Trial in United States (Iodine I 131 Tositumomab)

Completed
  • Non-Hodgkin's Lymphoma
  • Iodine I 131 Tositumomab
  • Bay Pines, Florida
  • +5 more
Sep 13, 2007

Non-Hodgkin's Lymphoma Trial in United States (Zevalin (ibritumomab tiuxetan), Rituxan (rituximab))

Terminated
  • Non-Hodgkin's Lymphoma
  • Zevalin (ibritumomab tiuxetan)
  • Rituxan (rituximab)
  • Huntsville, Alabama
  • +66 more
Sep 8, 2006